Today, the American Cancer Society Cancer Action Network (ACS CAN) was overjoyed to see the legislature pass oral chemotherapy fairness legislation. ACS CAN looks forward to seeing the Governor sign this critical legislation into law soon and celebrating our volunteers’ hard work to get this legislation over the finish line.
Earlier this week, 22 cancer patient and caregiver advocacy groups, including the American Cancer Society Cancer Action Network (ACS CAN), sent a letter to the Centers for Medicare & Medicaid Services (CMS) offering recommendations on how the agency should consider pharmaceutical therapeutic alternatives to selected oncology drugs for 2026 Medicare plans as they head into the negotiation process laid out in the Inflation Reduction Act (IRA).
The American Cancer Society Cancer Action Network (ACS CAN) was thrilled to see the Senate Health Policy Committee pass oral chemotherapy fairness legislation unanimously today.
FORT MYERS, FL -- The most rewarding part of our roles as oncology providers is the opportunity to extend and enrich lives. It enables people to witness cherished milestones such as a child’s wedding or the birth of a grandchild.
RALEIGH, N.C. – The North Carolina legislature passed the fiscal year 2023 biennium budget today that included $1 billion in additional funds for Medicaid expansion, allocated annually. The passage came after weeks of negotiations that have delayed implementation of Medicaid expansion.
ACS CAN and leading public health, consumer and provider groups filed an amicus curiae (or friend-of-the-court) brief in the case of Loper Bright Enterprises v. Raimondo urging the Supreme Court of the United States (SCOTUS) not to overturn the “Chervon deference." This would pose a significant threat to the country’s health care system by undermining the work of federal health agencies such as the Centers for Medicare and Medicaid Services (CMS).
Today, the American Cancer Society Cancer Action Network (ACS CAN) submitted a letter to the Centers for Medicare and Medicaid Services (CMS) commenting on draft guidance related to the maximum monthly cap on patient co-payments under prescription drug plans, referred to as the Medicare Prescription Payment Plan, which will begin in plan year 2025.
MINNEAPOLIS, Minn. – Emily Myatt was recognized as the country’s top government relations professional by the American Cancer Society Cancer Action Network (ACS CAN) in honor of her exceptional work advocat
La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN), la afiliada de defensa de ACS, continúa promoviendo políticas que amplían el acceso sostenible a la guía del paciente a fin de brindar un mejor apoyo a los pacientes con cáncer. Como parte de este esfuerzo, ACS CAN insta a los CMS a finalizar una política propuesta como parte de una norma de pago reciente que permitiría a Medicare implementar una estrategia de reembolso que asegurará el pago de los servicios de guía del paciente brindados por guías capacitados profesionalmente y certificados. ACS CAN también se unió a grupos de pacientes y proveedores en una segunda carta (en inglés) para recalcar la importancia fundamental del reembolso del servicio de guía del paciente a fin de facilitar este servicio esencial.
El viernes por la noche, la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) emitió una carta al Departamento de Salud y Servicios Humanos, el Departamento de Trabajo de los EE. UU. y el Servicio de Impuestos Internos (IRS, por sus siglas en inglés) comentando sobre la norma de seguros de duración limitada, a corto plazo (STLD) propuesta por las tres agencias desde el mes de julio.